vimarsana.com

Latest Breaking News On - Prnewswire inhibikase therapeutics inc - Page 1 : vimarsana.com

Inhibikase Therapeutics Announces Completion of the 501 Bioequivalence Study of IkT-001Pro

Inhibikase Therapeutics to Report Second Quarter Financial Results on August 14, 2023

BOSTON and ATLANTA, Aug. 7, 2023 /PRNewswire/ Inhibikase Therapeutics, Inc. , a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of.

Inhibikase Therapeutics Regains Compliance with Nasdaq Listing Requirements

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.